Reply: Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Yannick Palmowski; Maarten Boers; Frank Buttgereit

doi:10.1002/acr.23452

Reply: Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Yannick Palmowski
, Maarten Boers
, Frank Buttgereit

Humboldt University of Berlin

Research output: Contribution to journal › Comment/Letter to the editor › Academic

11 Downloads (Pure)

Abstract

We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

Original language	English
Pages (from-to)	577-578
Journal	Arthritis care & research
Volume	71
Issue number	4
Early online date	26 Oct 2017
DOIs	https://doi.org/10.1002/acr.23452
Publication status	Published - 1 Apr 2019

Keywords

Journal Article

Access to Document

10.1002/acr.23452

Reply-low-dose-glucocorticoids-in-rheumatoid-arthritis.pdfFinal published version, 116 KBLicence: Taverne

Cite this

@article{23f5866c8f504371a1e5a9a605c8742e,

title = "Reply: Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?",

abstract = "We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.",

keywords = "Journal Article",

author = "Yannick Palmowski and Maarten Boers and Frank Buttgereit",

year = "2019",

month = apr,

day = "1",

doi = "10.1002/acr.23452",

language = "English",

volume = "71",

pages = "577--578",

journal = "Arthritis care \& research",

issn = "2151-464X",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Reply: Low-dose glucocorticoids in rheumatoid arthritis

T2 - blurring the line between therapeutic dose and substitution therapy?

AU - Palmowski, Yannick

AU - Boers, Maarten

AU - Buttgereit, Frank

PY - 2019/4/1

Y1 - 2019/4/1

N2 - We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

AB - We would like to thank Masi and colleagues for their interest in our paper as well as for the interesting comments regarding the potential usefulness of neuroendocrine immune (NEI) testing in patients with rheumatoid arthritis (RA). When the first patient with rheumatoid arthritis (RA) was treated with glucocorticoids (GCs) in 1948, the effect was just overwhelming for that time. This article is protected by copyright. All rights reserved.

KW - Journal Article

U2 - 10.1002/acr.23452

DO - 10.1002/acr.23452

M3 - Comment/Letter to the editor

SN - 2151-464X

VL - 71

SP - 577

EP - 578

JO - Arthritis care & research

JF - Arthritis care & research

IS - 4

ER -

Reply: Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Abstract

Keywords

Access to Document

Fingerprint

Cite this